|
SLC4A1AP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.424200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.947600E-01 |
| Normal-vs-Stage2 |
2.919400E-01 |
| Normal-vs-Stage3 |
1.798530E-03 |
| Normal-vs-Stage4 |
1.574000E-02 |
| Stage1-vs-Stage2 |
5.237600E-01 |
| Stage1-vs-Stage3 |
3.543500E-03 |
| Stage1-vs-Stage4 |
4.271800E-02 |
| Stage2-vs-Stage3 |
1.899370E-01 |
| Stage2-vs-Stage4 |
3.866600E-01 |
| Stage3-vs-Stage4 |
6.148600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.747800E-02 |
| Normal-vs-AfricanAmerican |
8.683700E-03 |
| Normal-vs-Asian |
9.392600E-01 |
| Caucasian-vs-AfricanAmerican |
9.209700E-02 |
| Caucasian-vs-Asian |
5.396200E-01 |
| AfricanAmerican-vs-Asian |
2.337800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.020140E-02 |
| Normal-vs-Female |
3.554800E-01 |
| Male-vs-Female |
6.716500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.283700E-02 |
| Normal-vs-Age(41-60Yrs) |
7.848200E-02 |
| Normal-vs-Age(61-80Yrs) |
7.112300E-02 |
| Normal-vs-Age(81-100Yrs) |
3.375600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.387760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.476020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.315600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.586600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.050800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.228000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.282410E-01 |
| Normal-vs-Grade 2 |
6.248800E-01 |
| Normal-vs-Grade 3 |
8.158700E-03 |
| Normal-vs-Grade 4 |
8.177800E-04 |
| Grade 1-vs-Grade 2 |
1.444770E-01 |
| Grade 1-vs-Grade 3 |
1.660020E-02 |
| Grade 1-vs-Grade 4 |
2.936200E-03 |
| Grade 2-vs-Grade 3 |
8.396500E-03 |
| Grade 2-vs-Grade 4 |
8.750600E-04 |
| Grade 3-vs-Grade 4 |
1.532030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.503200E-01 |
| Normal-vs-ccB subtype |
7.92809999999866E-05 |
| ccA subtype-vs-ccB subtype |
5.65669999730289E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.126400E-02 |
| Normal-vs-N1 |
1.939770E-01 |
| N0-vs-N1 |
7.333000E-01 |
|
|
